The search giant unveils a frighteningly smart computer capable of teaching itself how to identify objects. The first thing it trains itself to look for? Cats
Continued here:
The search giant unveils a frighteningly smart computer capable of teaching itself how to identify objects. The first thing it trains itself to look for? Cats
Continued here:
NEW YORK--(BUSINESS WIRE)--
As the world celebrates Turings 100th birthday, IPsoft, the leading independent provider of autonomic IT services, looks back on the developments made in artificial intelligence to date, and what the world will look like once humans and machines are equal in intelligence:
Since the birth of computer science, man has been asking that question: Can machines really think? Some noteworthy philosophers have argued that artificial intelligence is impossible (Dreyfus), that it is immoral (Weizenbaum) and that the very concept of it is incoherent (Searle). Yet six decades ago, the father of computer science, Alan Mathison Turing, posed the Turing challenge. It stated that the age of machine intelligence would come when we could not discern between human and machine intelligence.
Since then, the world has wrestled with various cognitive models mimicking human intelligence. In 1966, Weizenbaum created Eliza to replicate the behavior of a Rogerian psychotherapist, which sometimes fooled people into thinking they were talking to a real person, by using rules that transformedusers questions. From the early Eliza and chatterbot modules to the more recent chess-playing Deep Blue, the world has started to wake up to the idea of machine intelligence. Today, we know computers can beat Jeopardy human champions (IBMs Watson), cars can drive themselves (Google) and machines can follow rudimentary commands (Apples Siri). But rather than just domain specific game-playing or office management kinds of tools, the question remains: Can machines graduate to really emulate and rival human intelligence?
Francis Crick, the Nobel Prize-winning father of modern genetics and discoverer of DNA helix structures, used to opine that there is a fundamental framework of ideas that are missing to be able to interpret approaches to achieving machine intelligence. One thing is clear: If we are to clone human intelligence in all its generic thinking and problem-solving grandeur, we cannot fake it. We need to sincerely emulate the human brain. We need to study hierarchical temporal memory systems to gain insight into the theoretical neuroscience behind how human brains work.
Too often, we are tempted to take the course of studying a specific body of knowledge and combating combinatorial explosion by throwing computing power to distill copious amounts of knowledge into supercomputers, said Chetan Dube, IPsoft CEO. We ignore a pivotal suggestion from Turing, that the scalable way to make machines think is not to simulate the adult mind, but to simulate a childs brain and then let it rapidly learn about the environment in which it finds itself. Adaptive learning is the key to unlocking the secrets of machine intelligence and fostering its ability to rival human intelligence.
Leveraging theoretical computer science principles including those taught by Turing, we are precipitously close to being the first to sincerely answer the six decade old Turing challenge. The idea would not be to just fake human behavior to win the Loebner prize, but to make a sincere emulation of human brain that is capable of adaptively learning just the way a child learns, and rapidly becoming smarter and smarter by its interactions with humans.
What impact will thinking machines have on modern times?
It is hard to tell all the ramifications of machines starting to learn and think. When a prodigious child is born, it is hard to tell of the impact he will have when he grows up. What we do know is that we are on the precipice of a transformation unlike any before. When microprocessors were invented, they were predominantly developed for calculators and traffic light controllers. Today, the world is a more efficient shrinking village through the use of Internet and mobile communications.
As opposed to any schools of thoughts that preach beware of machines, we believe machine intelligence will lead the optimal form of creative destruction. Take a look at the world today. We are enslaved. The Pareto principle holds. 80% of the time we are caught in the trap of doing the same 20% of canonical, yet mundane, chores. Whether it is vacuuming the floor or driving a car, we are currently slaves to ordinary chores. Machine intelligence will serve as the ultimate liberator. It will liberate mankind to engage in higher forms of creative expression.
See the original post:
27-06-2012 06:39
See original here:
Richard Evans The Use of Social Media Technologies in Aerospace and Defence - Video
Fairmont Consulting Group Will Provide Due Diligence And Strategic Advisory Services To Clients In Aerospace, Defense, Government Services, and IT/TelecomBoston, MA (PRWEB) June 28, 2012 Aerospace and defense business advisor Jay Wynn today announced the launch of Fairmont Consulting Group, a management consulting firm specializing in strategy and due diligence for clients active in aerospace ...
See the rest here:
Aerospace & Defense Advisor Jay Wynn Launches Fairmont Consulting Group
Election season is just around the corner in the U.S. and the countrys deep fiscal hole remains a political hot potato. If the U.S. Congress drags its feet again and does not meet a definitive agreement on the fiscal budget, aerospace and defense exchange traded funds will likely see turbulence.
Congress has until Jan. 1, 2013 to make things right or else a mix of tax hikes and $1.2 trillion in budget cuts are set to go off, reports Stacy Curtin for the Daily Ticker.
The aerospace and defense sector witnessed a similar scare last year when Congress dawdled ahead of raising the debt ceiling, which led to S&Ps downgrade on U.S. sovereign debt. [Budget, Spending Concerns Ground Aerospace and Defense ETFs]
Most economists estimate that without an answer to the countrys budget, there will be a $600 billion hole in the economy in 2013.
The defense sector would likely take the brunt of the hit, accounting for half of the budget cuts. About $500 billion in defense spending would be phased out over the next 10 years, with $55 billion immediately cut next year.
In a recent study conducted by National Association of Manufacturers, over 1 million private sector jobs could disappear by 2014 due to the poor fiscal budget. The job loss would translate to a 0.7% rise in unemployment and up to a 1% drop in GDP.
Lockheed Martin (LMT - News) has already warned that the majority of its 100,000 workforce is at risk due to federal budget cuts to defense. Additionally, other defense companies will also likely diminish their workforce in light of the constrained budget.
For more information on the defense sector, visit our aerospace & defense category.
Max Chen contributed to this article.
Originally posted here:
DAYTON, Ohio, June 27, 2012 /PRNewswire/ --Ball Aerospace & Technologies Corp. is a sponsor of the eighth annual Air Force Materiel Command (AFMC) Tattoo to be held on Friday, June 29, 2012.
The Freedom's Call Tattoo is hosted by the AFMC and Wright-Patterson Air Force Base to recognize the contributions of military veterans and their families. The annual event highlights Air Force Airmen and their capabilities to strengthen bonds with neighboring communities. This year's event will commemorate veterans' service during the Vietnam War.
Ball's Midwest Operations supports several Department of Defense organizations including the Air Force Research Laboratory (AFRL), the National Air and Space Intelligence Center (NASIC), and Aeronautical Systems Center in Dayton. Midwest Operations provides analysts, engineers and scientists with domain expertise for intelligence surveillance and reconnaissance, human performance and cyber missions. In the past decade, Ball's AerospaceDayton office has grown from its original 20 employees to more than 400.
Ball Aerospace & Technologies Corp. supports critical missions for national agencies such as the Department of Defense, NASA, NOAA and other U.S. government and commercial entities. The company develops and manufactures spacecraft, advanced instruments and sensors, components, data exploitation systems and RF solutions for strategic, tactical and scientific applications. For more information visit http://www.ballaerospace.com.
Ball Corporation (BLL) is a supplier of high quality packaging for beverage, food and household products customers, and of aerospace and other technologies and services, primarily for the U.S. government. Ball Corporation and its subsidiaries employ more than 14,500 people worldwide and reported 2011 sales of more than $8.6 billion. For the latest Ball news and for other company information, please visit http://www.ball.com.
Forward-Looking Statements
This release contains "forward-looking" statements concerning future events and financial performance. Words such as "expects," "anticipates, " "estimates" and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties which could cause actual results to differ materially from those expressed or implied. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Key risks and uncertainties are summarized in filings with the Securities and Exchange Commission, including Exhibit 99.2 in our Form 10-K, which are available on our website and at http://www.sec.gov. Factors that might affect our packaging segments include fluctuation in product demand and preferences; availability and cost of raw materials; competitive packaging availability, pricing and substitution; changes in climate and weather; crop yields; competitive activity; failure to achieve anticipated productivity improvements or production cost reductions; mandatory deposit or other restrictive packaging laws; changes in major customer or supplier contracts or loss of a major customer or supplier; political instability and sanctions; and changes in foreign exchange rates or tax rates. Factors that might affect our aerospace segment include: funding, authorization, availability and returns of government and commercial contracts; and delays, extensions and technical uncertainties affecting segment contracts. Factors that might affect the company as a whole include those listed plus: accounting changes; changes in senior management; the recent global recession and its effects on liquidity, credit risk, asset values and the economy; successful or unsuccessful acquisitions; regulatory action or laws including tax, environmental, health and workplace safety, including U.S. FDA and other actions affecting products filled in our containers, or chemicals or substances used in raw materials or in the manufacturing process; governmental investigations; technological developments and innovations; goodwill impairment; antitrust, patent and other litigation; strikes; labor cost changes; rates of return projected and earned on assets of the company's defined benefit retirement plans; pension changes; uncertainties surrounding the U.S. government budget and debt limit; reduced cash flow; interest rates affecting our debt; and changes to unaudited results due to statutory audits or other effects.
Excerpt from:
News | Evolution
Evidence is mounting against claims that dinosaurs could not have been endothermic, including a new analysis of fossil microstructures found in ruminants, lizards, dinosaurs and crocodiles
By Brian Switek and Nature magazine | June 27, 2012|
Studying modern mammals can provide insights into the metabolism of dinosaurs. Image: Walter Myers /Stocktrek Images/Corbis
Why do testicles hang the way they do? Is there an adaptive function to the female orgasm? What does it feel like to want to kill yourself? Does free will...
Read More
From Nature magazine
From museums to Hollywood films, dinosaurs are portrayed as highly active animals, but how they maintained this lifestyle isnt clear. For decades, palaeontologists have debated whether the physiology of non-avian dinosaurs was akin to that of today's cold-blooded reptiles or warm-blooded mammals. An important clue has now been uncovered not in Triceratops and its relatives, but in herbivorous mammals.
Palaeontologists have often examined bone microstructure in their investigations of dinosaur growth and physiology. Key to arguments on the subject are lines of arrested growth (LAGs) that represent an annual slowdown typically tied to a cold or dry season during which resources are scarce. These rings are seen in dinosaurs, as well as in creatures such as lizards and crocodiles, whose body temperatures are regulated by the external environment, but have not often been observed in the bones of endotherms creatures such as mammals that maintain high, constant body temperatures. But in a study published today in Nature, palaeontologist Meike Khler at the Autonomous University of Barcelona in Bellaterra, Spain, and her colleagues report that LAGs are present in ruminants from the tropics to the poles, greatly altering the context of the dinosaur-physiology debate.
Read more:
Dinosaurs Might Have Had Warm-Blooded Animals' Fast Metabolism
Studying modern mammals can provide insights into the metabolism of dinosaurs.
Walter Myers /Stocktrek Images/Corbis
From museums to Hollywood films, dinosaurs are portrayed as highly active animals, but how they maintained this lifestyle isnt clear. For decades, palaeontologists have debated whether the physiology of non-avian dinosaurs was akin to that of today's cold-blooded reptiles or warm-blooded mammals. An important clue has now been uncovered not in Triceratops and its relatives, but in herbivorous mammals.
Palaeontologists have often examined bone microstructure in their investigations of dinosaur growth and physiology. Key to arguments on the subject are lines of arrested growth (LAGs) that represent an annual slowdown typically tied to a cold or dry season during which resources are scarce. These rings are seen in dinosaurs, as well as in creatures such as lizards and crocodiles, whose body temperatures are regulated by the external environment, but have not often been observed in the bones of endotherms creatures such as mammals that maintain high, constant body temperatures. But in a study published today in Nature1, palaeontologist Meike Khler at the Autonomous University of Barcelona in Bellaterra, Spain, and her colleagues report that LAGs are present in ruminants from the tropics to the poles, greatly altering the context of the dinosaur-physiology debate.
Although LAGs have been found in mammalian bones before, Khler notes, this is the most comprehensive study of the structures in modern mammals across a range of latitudes. The herbivorous, hoofed mammals all slow their growth when faced with harsh conditions. This is the best way to cope with a cold or dry season, Khler says to shut down the energy demands of the body. The slowdown produces LAGs, even in endothermic organisms, and is an ancient mechanism for coping with lean times.
This means that LAGs cannot be used as an argument that dinosaurs could not have been endothermic, Khler says. In fact, the type of bone tissue seen in between dinosaur LAGs indicates the animals grew rapidly and sustained high metabolic rates. Dinosaur bone tissue is indistinguishable from that of todays endothermic ruminants, Khler says, meaning that dinosaurs were endothermic, too.
Anatomist John Hutchinson of London's Royal Veterinary College says that the study puts a nail in the coffin for the idea that mammals do not routinely exhibit LAGs as a natural part of their growth. And Hutchinson agrees that the study may help us to better understand dinosaur physiology.
Although he notes that the argument over dinosaur physiology involves a number of factors including histology and adaptations for rapid movement Hutchinson says that Khler's study provides additional evidence for dinosaur endothermy. The growing weight of evidence has been winning over scientists, myself included, to the view that endothermy evolved quite early in dinosaurs and was inherited by birds, he says.
Visit link:
Dinosaurs warm up
ATLANTA, June 27, 2012 /PRNewswire/ --Today's pathology practices face increasing billing complexities. Coding regulations are complicated, and penalties can be stiff if errors are made. Some physician groups miss valuable reimbursement revenue for certain services because they don't have the capacity or resources to bill for them electronically.
South Valley Pathology Associates in Bakersfield, CA, was one such group. With three full-time physicians, a small technical team and a three-person business office staff, South Valley was performing at an acceptable level while its billing was managed by an internal business manager. But when it made the switch to Orion HealthCorp, a leading medical billing and practice management company, it began to realize what it had been missing.
"Orion made us aware of revenue opportunities we didn't know existed," said Dr. Bruce Swinyer, medical director of the practice. "We never collected for clinical services (blood draws and testing), because the lab operates independent of us. Orion showed us how we could begin collecting for those services as well as for the anatomical (tissue) pathology services we perform. That has made a huge difference for us. We have streamlined our billing processes and optimized reimbursement."
40% reimbursement increase in 2011Typically, smaller pathology practices don't have the ability to bill for clinical services because the charges are sent electronically and the individual collections are small, so handling them manually usually costs more than the actual reimbursement. Orion has the software capabilities and the expertise to do the job correctly. With the addition of clinical collections and increased collections for anatomical services with Orion, the practice's reimbursement from Medicare and private insurers grew by 40% in 2011, a record year for the practice.
Also, since partnering with Orion in 2010, Dr. Swinyer says he has greater insight into how the business side of the practice is performing. That is extremely important in today's economy. "Orion's e-mail month-end statement of collections and weekly updates on collected revenue are a great asset," he said. "Also, being able to see revenue broken out by anatomical and clinical pathology services is very helpful."
Transparency into vital signs"They established credibility from the outset," he said. "And when they showed me their reporting capabilities and the visibility provided into our practice, I knew it was going to be a good match."
Osmium(SM), Orion's Business Intelligence (BI) tool that provides transparency into the practice's vital signs, makes much of that visibility possible. It puts data in relevant form so Dr. Swinyer can see precisely, in real time, how the practice is performing and how Orion is performing while identifying opportunities for improvement and future growth.
"We know Osmium is a valuable tool, but it is always good to see it validated in the marketplace this way, and to see the value it is providing Dr. Swinyer's practice," said Dale Brinkman, president of Orion Rand and Orion Western Skies Billing. "We work hard at Orion to see that our clients are satisfied, and this is proof positive that we are doing the job right."
Today, the practice's billing is handled much more professionally and objectively, giving Dr. Swinyer a new-found confidence. He is also lab director at a smaller hospital in Kern Valley. With his busy schedule, he appreciates knowing that the business side of the practice is in good hands with Orion.
According to Dr. Swinyer, Orion delivers benefits to the practice at every level. "Not only does their billing yield strong results, but they are also exceptionally responsive to our requests," he said. "Their team is extremely approachable, and I feel very comfortable dealing with them. It's a great partnership, and I have peace of mind knowing that our practice is running smoothly."
See the article here:
California Pathology Practice Increases Reimbursement by 40%
NEWPORT BEACH, CA--(Marketwire -06/27/12)- Adia Nutrition, Inc. (ADIA) is proud to announce the launch of a revolutionary new product called Adia Slim. It is believed to be the first probiotic beverage with an appetite suppressant in the $61 billion diet and weight loss industry.
Adia Slim is a raspberry lemonade flavored beverage powder which contains LuraLean. LuraLean is a fiber from the root of a Japanese plant called Konjac. The fiber expands in your stomach shortly after you drink it, and gives you a feeling of fullness so you eat less.
This fiber is then combined with probiotics to make sure the food you eat is then digested more efficiently.
"Adia Slim is a revolutionary step in weight management," said Adia CEO Wen Peng. "We believe that Adia Slim gives dieters a tool to help control the quantity of food people consume. This tool, combined with diet and exercise should show results. As with any health program, please speak to your doctor in connection with any lifestyle change. Like all our Adia products, Adia Slim contains convenient and shelf stable 'On the Go' probiotics that require no refrigeration together with essential vitamins and minerals. Adia Nutrition are the perfect products for the busy 'on the go' family, from mom and dad to the kids."
Adia Slim can be ordered by calling 1-877-207-6321 or by visiting http://www.adianutrition.com to order online or find the local retailer near you.
About Adia Nutrition, Inc.
About Adia Nutrition, Inc. (ADIA) is a company specializing in shelf stable probiotics. Currently, Adia offers five flavors of probiotic powder and two flavors of probiotic chews. Adia sells their products across the country in independent pharmacies, health food stores, fitness centers and grocery store chains. In states and countries where Adia does not yet have retail distribution partners you can find Adia online. According to a market research report titled 'Probiotics Market,' published by Markets and Markets (www.marketsandmarkets.com), the global probiotics market is expected to be worth US$ 32.6 billion by 2014. Moreover, the global market is expected to record a CAGR of 12.6%.
Forward-Looking Statements
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," and "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file with the U.S. Securities and Exchange Commission (SEC).
Read more from the original source:
Adia Nutrition, Inc. (ADIA.PK) Announces the Launch of Adia Slim, Which Is Believed to Be the First Probiotic With an ...
Oxidative Medicine and Cellular Longevity Article Reports Protandim(R) Protects Human Coronary Artery Endothelial Cells Against Oxidative Challenge
SALT LAKE CITY, June 27, 2012 (GLOBE NEWSWIRE) -- LifeVantage Corporation (LFVN), the leader in Nrf2 science and the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, announced today that a new peer-reviewed original research article involving Protandim was recently published in the scientific journal Oxidative Medicine and Cellular Longevity.
The study, conducted by researchers at Colorado State University, examined cells in vitro that line the vessels involved in coronary artery disease and demonstrated that Protandim induced the movement of the transcription factor Nrf2 into the nuclei of the cells. It also showed significant Protandim-dependent increases in phase II protective enzymes, including heme oxygenase-1, superoxide dismutase 1, glutathione reductase, and the antioxidant enzyme NQO1. When cells were challenged with oxidative stress by a four-hour exposure to hydrogen peroxide, 35% of control cells died via apoptosis whereas cells pretreated with Protandim for 12 hours were protected seven-fold, resulting in only a 5% death rate by apoptosis. Finally, experiments using the small interfering RNA (siRNA) technique to block the cells' ability to produce Nrf2, confirmed that Protandim's mechanism of action is indeed Nrf2-dependent, in both specific enzyme induction and functional protection of the cells from oxidative stress.
"The cells studied in this project represent 'ground zero,' the epicenter for damage that results in human coronary artery disease. Much research suggests that this damage begins with oxidative stress," said Dr. Joe McCord, LifeVantage Chief Science Officer. "It is impressive that the activation of Nrf2 produces such significant resistance and protection against oxidative stress in these cells."
"This work was conceived and conducted by investigators at Colorado State University, with funding provided by CSU Proteomics and Metabolomics Facility Academic Enrichment Program and a Colorado State University CAHS mini-grant," stated Douglas Robinson, LifeVantage President and CEO. "LifeVantage greatly appreciates the remarkable academic interest in Protandim shown by researchers such as Drs. Karyn Hamilton and Ben Miller, the study's co-principal investigators, and their colleagues. This scholarly contribution underscores the potential being recognized by the biomedical research community for Protandim with regard to health conditions associated with oxidative stress."
Authored by Elise L. Donovan, Benjamin F. Miller, Joe M. McCord, Danielle J. Reuland, and Karyn L. Hamilton, the study titled, "Phytochemical Activation of Nrf2 Protects Human Coronary Artery Endothelial Cells against an Oxidative Challenge," is published in the open access online journal Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 132931, doi:10.1155/2012/132931.
The study may be found at http://www.ncbi.nlm.nih.gov/pubmed/22685617.
About Protandim(R) The Nrf2 Synergizer(R)
Protandim(R), the Nrf2 Synergizer(R), is a clinically demonstrated supplement that provides substantial benefits for healthy aging by activating Nrf2. Nrf2 is a protein messenger contained in every cell of the body. When activated, Nrf2 enters the cell nucleus and turns on hundreds of survival genes, defensive, stress responsive, cytoprotective genes that enable cells to survive in the face of several different kinds of stress, particularly oxidative stress. This patented Nrf2-activating therapy works in a very different way than conventional antioxidant supplements. Unlike vitamin or carotenoid-containing products that have proven to be largely ineffective in reducing oxidative stress caused by free radicals, Protandim is an indirect antioxidant therapy, which has been demonstrated to stimulate the body's production of its own powerful antioxidant enzymes and other stress-related gene products. Protandim works at the cellular level, and has been shown to trigger cells to naturally increase production of protective antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione synthase, while decreasing production of pro-inflammatory signals.
Under the Dietary Supplement Health and Education Act, Protandim is considered a "dietary supplement". LifeVantage products are not intended to treat, cure, prevent or mitigate any disease.
View post:
LifeVantage Announces Protandim(R) Subject of New Peer-Reviewed Article
PHOENIX Analyzing the DNA samples of youngsters who have not been found guilty of any crime is an unconstitutional warrantless search, the Arizona Supreme Court ruled Wednesday.
In a unanimous decision, the justices said the state is free to force juveniles accused of certain serious offenses to provide a DNA sample. Justice Andrew Hurwitz, writing for the court, said that is little difference than fingerprints or mug shots.
But Hurwitz said that legal parallel ceases to exist once the state submits that sample for processing by the Department of Public Safety crime laboratory. He said that processing results in the state obtaining uniquely identifying information about individual genetics.''
What it also means, Hurwitz said, is that DNA profile is placed into both state and national databases so police agencies can use it to see if a youngster is linked to any unsolved crimes. The justices said that, absent a juvenile actually being adjudicated delinquent, there is no reason for the government to have that information.
Having a DNA profile before adjudication may conceivably speed such investigations,'' he wrote.
But one accused of a crime, although having diminished expectations of privacy in some respects, does not forfeit Fourth Amendment protections with respect to other offenses not charged absent either probable cause or reasonable suspicion,'' Hurwitz continued. An arrest for vehicular homicide, for example, cannot alone justify a warrantless search of an arrestee's financial records to see if he is also an embezzler.''
Wednesday's ruling could have broader implications.
Christina Phillis, director of Maricopa County's Office of Public Advocate, noted that other Arizona laws require similar testing of DNA samples taken from adults at the time of arrest. To date, though, Phillis said no adult who has not yet been convicted has mounted a similar challenge to this one.
This case and the logic behind it espoused by Hurwitz could provide the framework for the court to consider the issue.
Maricopa County Attorney Bill Montgomery, whose office had defended the DNA testing, said in a prepared statement he was pleased the court will allow samples to still be taken. But he disagreed with the conclusion that actually processing the sample amounted to any sort of invasion of privacy.
Read more:
Judge rules DNA analysis of unconvicted juveniles illegal
Analyzing the DNA samples of juveniles who have not been found guilty of any crime is an unconstitutional warrantless search, the Arizona Supreme Court ruled Wednesday.
In a unanimous decision, the justices said the state may force juveniles accused of certain serious offenses to provide a DNA sample. Justice Andrew Hurwitz, writing for the court, said that is little different than fingerprints or mug shots.
But Hurwitz said that legal parallel ceases to exist once the state submits that sample for processing by the Department of Public Safety crime laboratory.
He said that by doing the lab processing, the state obtains "uniquely identifying information about individual genetics."
What it also means, Hurwitz said, is that DNA profile is placed into both state and national databases so police agencies can use it to see if a youth is linked to any unsolved crimes. The justices said that, absent a juvenile actually being found delinquent of a crime, there is no reason for the government to have that information.
"Having a DNA profile before adjudication may conceivably speed such investigations," he wrote.
"But one accused of a crime, although having diminished expectations of privacy in some respects, does not forfeit Fourth Amendment protections with respect to other offenses not charged absent either probable cause or reasonable suspicion," Hurwitz continued. "An arrest for vehicular homicide, for example, cannot alone justify a warrantless search of an arrestee's financial records to see if he is also an embezzler."
The ruling could have broader implications.
Christina Phillis, director of Maricopa County's Office of Public Advocate, noted that other Arizona laws require similar testing of DNA samples taken from adults at the time of arrest. To date, though, Phillis said no adult who has not yet been convicted has mounted a similar challenge to this one. This case - and the logic espoused by Hurwitz - could provide the framework for the court to consider the issue.
Maricopa County Attorney Bill Montgomery, whose office had defended the DNA testing, said he was pleased the court will allow samples to be taken. But he disagreed with the conclusion that processing the sample amounted to invasion of privacy.
The rest is here:
AZ high court limits analysis of juvenile defendants' DNA
CARMARTHENSHIRE, Wales, June 27 (UPI) -- Wales says it has recorded the DNA of all its native flowering plants, which may help conservation and lead to new drugs to fight illnesses.
It is the first country in the world to create such a database, the National Botanic Garden of Wales said.
Wales has about 75 percent of the flowering plants found in Britain, and the database contains 1,143 plants and conifers, officials said.
The Barcode Wales project has been led by Natasha de Vere, head of conservation and research from the National Botanic Garden in Carmarthenshire, the BBC reported Wednesday.
Barcodes are short DNA sequences allowing plants to be identified from pollen grains, seed pieces, or roots and wood.
"Wales is now in the unique position of being able to identify plant species from materials which in the past would have been incredibly difficult or impossible," de Vere said.
"Through the Barcode Wales project, we have created a powerful platform for a broad range of research from biodiversity conservation to human health."
In the next phase of a three-year project, non-native plants introduced by humans will have their DNA recorded, officials said.
The rest is here:
Wales records DNA of all native plants
ScienceDaily (June 27, 2012) Researchers at the California Institute of Technology (Caltech) have been able, for the first time, to watch viruses infecting individual bacteria by transferring their DNA, and to measure the rate at which that transfer occurs. Shedding light on the early stages of infection by this type of virus -- a bacteriophage -- the scientists have determined that it is the cells targeted for infection, rather than the amount of genetic material within the viruses themselves, that dictate how quickly the bacteriophage's DNA is transferred.
"The beauty of our experiment is we were able to watch individual viruses infecting individual bacteria,"says Rob Phillips, the Fred and Nancy Morris Professor of Biophysics and Biology at Caltech and the principal investigator on the new study. "Other studies of the rate of infection have involved bulk measurements. With our methods, you can actually watch as a virus shoots out its DNA."
The new methods and results are described in a paper titled "A Single-Molecule Hershey-Chase Experiment," which will appear in the July 24 issue of the journal Current Biology and currently appears online. The lead authors of that paper, David Van Valen and David Wu, completed the work while graduate students in Phillips's group.
In the well-known 1952 Hershey-Chase experiment, Alfred Hershey and Martha Chase of the Carnegie Institution of Washington in Cold Spring Harbor convincingly confirmed earlier claims that DNA -- and not protein -- was the genetic material in cells. To prove this, the researchers used bacteriophages, which are able to infect bacteria using heads of tightly bundled DNA coated in a protein shell. Hershey and Chase radiolabeled sulfur, contained in the protein shell but not in the DNA, and phosphorus, found in the DNA but not in the protein shell. Then they let the bacteriophages infect the bacterial cells. When they isolated the cells and analyzed their contents, they found that only the radioactive phosphorus had made its way into the bacteria, proving that DNA is indeed the genetic material. The results also showed that, unlike the viruses that infect humans, bacteriophages transmit only their genetic information into their bacterial targets, leaving their "bodies" behind.
"This led, right from the get-go, to people wondering about the mechanism -- about how the DNA gets out of the virus and into the infected cell," Phillips says. Several hypotheses have focused on the fact that the DNA in the virus is under a tremendous amount of pressure. Indeed, previous work has shown that the genetic material is under more pressure within its protein shell than champagne experiences in a corked bottle. After all, as Phillips says, "There are 16 microns [16,000 nanometers] of DNA in a tiny 50-nanometer-sized shell. It's like taking 500 meters of cable from the Golden Gate Bridge and putting it in the back of a FedEx truck."
Phillips's group wanted to find out whether that pressure plays a dominant role in transferring the DNA. Instead, he says, "What we discovered is that the thing that mattered most was not the pressure in the bacteriophage, but how much DNA was in the bacterial cell."
The researchers used a fluorescent dye to stain the DNA of two mutants of a bacteriophage known as lambda bacteriophage -- one with a short genome and one with a longer genome -- while that DNA was still inside the phage. Using a fluorescence microscope, they traced the glowing dye to see when and over what time period the viral DNA transferred from each phage into an E. coli bacterium. The mean ejection time was about five minutes, though that time varied considerably.
This was markedly different from what the group had seen previously when they ran a similar experiment in a test tube. In that earlier setup, they had essentially tricked the bacteriophages into ejecting their DNA into solution -- a task that the phages completed in less than 10 seconds. In that case, once the phage with the longer genome had released enough DNA to make what remained inside the phage equal in length to the shorter genome, the two phages ejected DNA at the same rate. Therefore, Phillips's team reasoned, it was the amount of DNA in the phage that determined how quickly the DNA was transferred.
But Phillips says, "What was true in the test tube is not true in the cell." E. coli cells contain roughly 3 million proteins within a box that is roughly one micron (1,000 nanometers) on each side. Less than 10 nanometers separate each protein from its neighbors. "There's no room for anything else," Phillips says. "These cells are really crowded."
And so, when the bacteriophages try to inject their DNA into the cells, the factor that limits the rate of transfer is how jam-packed those cells are. "In this case," Phillips says, "it had more to do with the recipient, and less to do with the pressure that had built up inside the phage."
See the original post:
Physics of going viral: Rate of DNA transfer from viruses to bacteria measured
MIT has named a new provost. The former head of MITs Dept. of Biology, professor Chris Kaiser, will take on the role as provost, replacing MITs President-elect Rafael Reif, the institute announced today.
Kaiser, who has been a cell biologist and professor of biology, has been at MIT since 1991. The professor, 55, chaired the Dept. of Biology from 2004 until earlier this year.
As someone who grew up at MIT first as a graduate student and then as a member of the biology faculty I am extremely grateful to President-elect Reif for giving me the opportunity to serve the Institute in this capacity, Kaiser said in a statement. At MIT, innovation is the norm, and as provost I plan not only to build upon our already-strong programs, but also to continue to foster inventive new directions in education and research.
Kaiser was selected by Reif, the outgoing provost, who will take on his role as president on July 2. Reif selected Kaiser after consulting faculty members and students, according to MIT. The selection was then was confirmed by a vote of the Executive Committee of the MIT Corporation.
In his new role as provost, Kaiser will be responsible for the Institutes educational programs, as well as for the recruitment, promotion and tenuring of faculty. Kaiser will also work with the deans of MITs five schools to establish priorities and will work with the vice president for research and associate provost regarding research priorities.
As the head of the Dept. of Biology, Kaiser managed 14 new junior faculty in the department and in affiliated research institutions including the Whitehead Institute for Biomedical Research, the Koch Institute for Integrated Cancer Research, and the Broad Institute.
His efforts in genetic, biochemical and structural biology research methods have led to the identification of numerous genes and mutations involved in these processes.
Public release date: 27-Jun-2012 [ | E-mail | Share ]
Contact: Kevin Korpics kevin@engconfintl.org Engineering Conferences International
Oligonucleotide technologies, such as siRNA, tap into endogenous, highly conserved and specific catalytic mechanisms to efficiently regulate gene expression. As such, they have the potential to enable the development of novel therapeutic options for disease targets previously considered un-druggable by conventional small molecule and biologics means. However, despite the promise, clinical development has been hindered by the challenges encountered by identifying and developing safe and efficacious delivery formulations.
Since its discovery in 1998, RNA silencing has attracted much attention, with over 50,000 peer-reviewed publications, multiple national and international conferences, and significant investment in the biotech and large pharma with the goal of developing new siRNA-based therapies. Despite the interest and investment this has proven to be more difficult that first envisioned. It is widely recognized that there are gaps in our basic understanding on how to best harness this technology for therapeutic use.
The major topics to be discussed are:
Liposomes, nanosomes, polymeric and nano-particulate delivery vehicles RNA chemical modifications and conjugates to enable delivery Protein transduction domain as delivery platforms Mechanisms of cellular uptake and endosomal escape Biophysical characterization methods siRNA delivery vehicle toxicology Local and systemic siRNA delivery case studies
Confirmed Speakers Achim Aigner, Philipps-University Marburg, Germany Saghir Akhtar, Kuwait University, Kuwait Eben Alsberg, Case Western Reserve University, USA Dan Anderson, MIT, USA Tomohiro Asai, University of Shizuoka, Japan Himanshu Brahmbhatt, EnGeneIC Ltd, Australia Bob Brown, Dicerna, USA Kenneth Clark, GlaxoSmithKline, UK Pieter Cullis, University of British Columbia, Canada Mark E. Davis, California Institute of Technology, USA Derek M. Dykxhoorm, University of Miami Miller School of Medicine, USA Xavier de Mollerat Du Jeu, Life Technologies, USA Omid Farokhzad, Harvard Medical School, USA Elena Feinstein, Quark Pharma, Israel / USA Mauro Ferrari, The Methodist Hospital Research Institute, USA Mercedes Gonzlez-Juarrero, Colorado State University, USA Tatsuhiro Ishida, The University of Tokushima, Japan Rudy Juliano, University of North Carolina Chapel Hill, USA Jan Kamps, University of Groningen, The Netherlands Kazunori Kataoka, University of Tokyo, Japan Jrgen Kjems, rhus University, Denmark Troels Koch, Santaris Pharma A/S, Denmark / USA lo Langel, Stockholm University, Sweden Gabriel Lpez-Berestein, The University of Texas MD Anderson Cancer Center, USA Zheng-Rong Lu, Case Western Reserve University, USA Jennifer MacDiarmid, EnGeneIC Ltd, Australia Ram I. Mahato, University of Tennessee Health Science Center, USA Muthiah Manoharan, Alnylam Pharmaceuticals, USA Nigel A.J. McMillan, Diamantina Institute, University of Queensland, Australia X in Ming, University of North Carolina Chapel Hill, USA Tamara Minko, Rutgers University, USA Andrs Montefeltro, nLife Therapeutics, Spain Sterghios Moschos, University of Westminster, UK Deborah Palliser, Albert Einstein School of Medicine, USA Dan Peer, Tel Aviv University, Israel Jean Phillipe Pellois, Texas A&M University, USA Blake Peterson, The University of Kansas, USA Tariq M. Rana, Sanford-Burnham Medical Research Institute, USA Steven L. Regen, Lehigh University, USA John Rossi, City of Hope, Duarte, USA Dmitry Samarsky, RiboBio, China Ansgar Santel, Silence Therapeutics AG, Germany Alan D. Schreiber, ZaBeCor Pharmaceuticals, Inc., USA Sabine Schreidler, Sanofi-Aventis, Germany Georg Sczakiel, University of Lbeck, Germany Peter H. Seeberger, Max Planck Institute of Colloids and Interfaces, Berlin, Germany Rita Serda, Methodist Hospital Research Institute, USA Mouldy Sioud, Norwegian Radium Hospital, Norway Anil Sood, MD Anderson Cancer Center, USA Janos Szebeni, Semmelweis University, Budapest, Hungary C. Shad Thaxton, Northwestern University, USA Ernst Wagner, Ludwig-Maximilians-Universitat, Munchen, Germany Roberto Weinmann, Sylentis, Spain Johannes Winkler, University of Vienna, Austria You-Yeon Won, Purdue University, USA Matthew Wood, Oxford University, UK Miqin Zhang, University of Washington, USA
###
Submission of Abstracts
ABSTRACT SUBMISSION IS NOW OPEN
The rest is here:
Oligonucleotide Delivery: Biology, Engineering and Development Conference
By Sarah N. Mattero, Globe Correspondent
Chris A. Kaiser, professor and former chairman of the Department of Biology at MIT, has been named the colleges new provost.
Kaiser succeeds L. Rafael Reif, who recently was appointed MITs president. Reif and Kaiser will assume the positions of president and provost, respectively, on July 2.
Kaiser, 55, of Concord, has been a member of faculty since 1991. He served as the biology department chairman from 2004 until earlier this year.
A distinguished scholar and a master teacher in his field, he has also played a key role on a number of Institute-wide committees, advancing the broader mission of MIT with curiosity, creativity, empathy and a marvelous sense of humor, Reif said of Kaiser in a statement. I have no doubt that he will thrive as provost.
The provost is MITs senior academic and budget officer who also oversees the recruitment and promotion of faculty with overall responsibility for the schools educational programs.
See more here:
MIT taps Chris Kaiser, former head of biology department, as new provost
DUBLIN--(BUSINESS WIRE)--
Research and Markets (http://www.researchandmarkets.com/research/76ggj5/dictionary_of_deve) has announced the addition of John Wiley and Sons Ltd's new book "Dictionary of Developmental Biology and Embryology, 2nd Edition" to their offering.
A newly-revised edition of the standard reference for the field today updated with new terms, major discoveries, significant scientists, and illustrations
Developmental biology is the study of the mechanisms of development, differentiation, and growth in animals and plants at the molecular, cellular, and genetic levels. The discipline has gained prominence in part due to new interdisciplinary approaches and advances in technology, which have led to the rapid emergence of new concepts and words. The Dictionary of Developmental Biology and Embryology, Second Edition is the first comprehensive reference focused on the field's terms, research, history, and people.
This authoritative A-to-Z resource covers classical morphological and cytological terms along with those from modern genetics and molecular biology. Extensively cross-referenced, the Dictionary includes definitions of terms, explanations of concepts, and biographies of historical figures. Comparative aspects are described in order to provide a sense of the evolution of structures, and topics range from fundamental terminology, germ layers, and induction to RNAi, evo-devo, stem cell differentiation, and more. Readers will find such features of embryology and developmental biology as:
- Vertebrates
- Invertebrates
- Plants
- Developmental genetics
- Evolutionary developmental biology
Visit link:
Research and Markets: Dictionary of Developmental Biology and Embryology, 2nd Edition
Latin King details plot in trial on gun, narcotics conspiracy
Luis Tambito, an ex-Latin King attack coordinator, testified Wednesday about a 2010 plan to kill John Maldonado. Tambito said the gang suspected Maldonado of killing an aspiring member and wanted revenge. Above, Shameeka Burks, Maldonados former girlfriend, in Newburgh the day after his death.CHET GORDON/Times Herald-Record
Published: 2:00 AM - 06/28/12
WHITE PLAINS John "Tarzan" Maldonado spent his final hours in what he must have thought was a safe place.
An FBI video camera recorded him standing, a drink in hand, on the corner of William Street and Benkard Avenue as it grew dark on March 12, 2010. Even then, Luis "King Luch" Tambito testified on Wednesday, the Latin Kings were laying plans to kill him.
A 20-year-old named Jerome "Rude Boy" Scarlett had died in a shooting the night before. A memorial of lit candles shined in the video as the Kings wandered in and out of the frame.
Tambito testified Scarlett and Maldonado both hoped to become full gang members and that he had selected them to shoot rival Bloods on Lander Street. Maldonado came back. Scarlett didn't. The Kings were unhappy, and rumors soon circulated that it was Maldonado who shot Scarlett. Tambito said they were convinced when a friendly Blood told them none of the Bloods had shot back.
"We had heard rumors that Tarzan was infiltrating our gang that he was working with the Bloods and that's why he killed Rude Boy," Tambito said.
Tambito was once the gang's Third Crown, a position responsible for coordinating attacks on rivals and punishing Kings who broke gang rules. He admitted to murders, stabbings, beatings and shootings as part of a plea agreement. On Wednesday, he testified in federal court in the case of four defendants Nelson "King Murder" Calderon, Angelo "King Truth" DeLeon, Eva Cardoza and Wilfredo "Frito" Sanchez who face gun and narcotics conspiracy charges.
Defense attorneys said Tambito is a lifelong thug who chose violence and self-preservation virtually every time he had an opportunity to do right. By his own admission, Tambito orchestrated Maldonado's murder and then watched the dying 21-year-old twitch and mumble, eventually heading up the block to buy a couple of beers. He could have faced death penalty-eligible charges but agreed to cooperate with the government.
Go here to read the rest:
In testimony, anatomy of a homicide